3 Biotech Stocks That Could Double In 2026
The biotech sector is one that’s become red-hot, at least in recent years.
The biotech sector is one that’s become red-hot, at least in recent years.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks.
CIEN, DG and CMC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 19, 2026.
Bank stocks haven’t exactly been the darlings of income investors over the past few years, for understandable reasons.
Pentair’s 50th consecutive dividend hike makes it the newest “Dividend King.” This is an exclusive club, but it contains some cautionary tales.
Chip stocks react to the Greenland headlines and the uncertainty of trade.
Alphabet has established itself as a clear AI leader. Salesforce has set the groundwork to become a leader in agentic AI.
The S&P 500 is chugging along at a solid rate, as it’s up 17% over the past year and up 2.5% over the past month.
Companies with sound business models and strong competitive advantages can provide steady long-term returns.
Quantum computing could be a game changer as it may solve problems deemed impossible today.